Skip to main content
SpringerLink
Log in

Medical Consequences of Cannabis Use

  • Chapter
  • First Online:
Cannabis Use Disorders

  • 1759 Accesses

Abstract

Consumed by an estimated 2.5% of the world’s population, cannabis is the most popular illicit drug. Depending on age of onset, frequency, duration, and other variables, cannabis use can be associated with a broad spectrum of medical consequences, the range of which mirrors the physiological ubiquity and versatility of the endocannabinoid system. Importantly, the adverse consequences of cannabis use can progress to become overt clinical conditions, independently of the development of a cannabis use disorder. The purpose of this chapter is to present an updated overview of these adverse health effects of cannabis use and the implications of our current understanding vis-á-vis public health and research agendas moving forward.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Adams PM, Barratt ES. Effect of chronic marijuana administration of stages of primate sleep-wakefulness. Biol Psychiatry. 1975;10:315–22.

    CAS  PubMed  Google Scholar 

  2. Ahrnsbrak R, Bose J, Hedden SL, Lipari RN, Park-Lee E. Key Substance Use and Mental Health Indicators in the United States: Results from the 2016 National Survey on Drug Use and Health. edited by (HHS) USDoHaHS. Rockville: Substance Abuse and Mental Health Services Administration (SAMHSA); 2017.

    Google Scholar 

  3. Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004;53:1566–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Alshaarawy O, HA E. Cannabis use and blood pressure levels: United States National Health and Nutrition Examination Survey, 2005-2012. J Hypertens. 2016;34:1507–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Andrews KH, Bracero LA. cannabinoid hyperemesis syndrome during pregnancy: a case report. J Reprod Med. 2015;60:430–2.

    PubMed  Google Scholar 

  6. Angarita GA, Emadi N, Hodges S, Morgan PT. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addict Sci Clin Pract. 2016;11:9.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Azofeifa A, Mattson ME, Grant A. Monitoring marijuana use in the United States: challenges in an evolving environment. JAMA. 2016;316:1765–6.

    Article  PubMed  Google Scholar 

  8. Babson KA, Sottile J, Morabito D. Cannabis, cannabinoids, and sleep: a review of the literature. Curr Psychiatry Rep. 2017;19:23.

    Article  PubMed  Google Scholar 

  9. Bancks MP, Pletcher MJ, Kertesz SG, Sidney S, Rana JS, Schreiner PJ. Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Diabetologia. 2015;58:2736–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Banerjee A, Singh A, Srivastava P, Turner H, Krishna A. Effects of chronic bhang (cannabis) administration on the reproductive system of male mice. Birth Defects Res B Dev Reprod Toxicol. 2011;92:195–205.

    Article  CAS  PubMed  Google Scholar 

  11. Barratt ES, PM A. Chronic marijuana usage and sleep-wakefulness cycles in cats. Biol Psychiatry. 1973;6:207–14.

    CAS  PubMed  Google Scholar 

  12. Barratt ES, Beaver W, White R. The effects of marijuana on human sleep patterns. Biol Psychiatry. 1974;8:47–54.

    CAS  PubMed  Google Scholar 

  13. Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst. 1998;90:1198–205.

    Article  CAS  PubMed  Google Scholar 

  14. Benowitz NL, Jones RT. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin Pharmacol Ther. 1975;18:287–97.

    Article  CAS  PubMed  Google Scholar 

  15. Berg CJ, Henriksen L, Cavazos-Rehg PA, Haardoerfer R, Freisthler B. The emerging marijuana retail environment: Key lessons learned from tobacco and alcohol retail research. Addict Behav. 2018;81:26–31.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Bloor RN, Wang TS, Spanel P, Smith D. Ammonia release from heated ‘street’ cannabis leaf and its potential toxic effects on cannabis users. Addiction. 2008;103:1671–7.

    Article  PubMed  Google Scholar 

  17. Blumentrath CG, Dohrmann B, Ewald N. Cannabinoid hyperemesis and the cyclic vomiting syndrome in adults: recognition, diagnosis, acute and long-term treatment. GMS e-journal. 2017;15:Doc06.

    PubMed  PubMed Central  Google Scholar 

  18. Brancheau D, Blanco J, Gholkar G, Patel B, Machado C. Cannabis induced asystole. J Electrocardiol. 2016;49:15–7.

    Article  PubMed  Google Scholar 

  19. Brents LK. Marijuana, the endocannabinoid system and the female reproductive system. Yale J Biol Med. 2016;89:175–91.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Brown QL, Sarvet AL, Shmulewitz D, Martins SS, Wall MM, Hasin DS. Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002-2014. JAMA. 2017;317:207–9.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Brown TT, Dobs AS. Endocrine effects of marijuana. J Clin Pharmacol. 2002;42:90S–6S.

    Article  CAS  PubMed  Google Scholar 

  22. Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004;161:1967–77.

    Article  PubMed  Google Scholar 

  23. Budney AJ, Moore BA, Vandrey RG, Hughes JR. The time course and significance of cannabis withdrawal. J Abnorm Psychol. 2003;112:393–402.

    Article  PubMed  Google Scholar 

  24. Casier I, Vanduynhoven P, Haine S, Vrints C, Jorens PG. Is recent cannabis use associated with acute coronary syndromes? An illustrative case series. Acta Cardiol. 2014;69:131–6.

    Article  PubMed  Google Scholar 

  25. Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014;144:12–41.

    Article  CAS  PubMed  Google Scholar 

  26. Chase PB, Hawkins J, Mosier J, Jimenez E, Boesen K, Logan BK, Walter FG. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs. Clin Toxicol. 2016;54:14–9.

    Article  CAS  Google Scholar 

  27. Clark BC, Georgekutty J, Berul CI. Myocardial ischemia secondary to synthetic cannabinoid (K2) use in pediatric patients. J Pediatr. 2015;167:757–761 e751.

    Article  PubMed  Google Scholar 

  28. Conroy DA, Arnedt JT. Sleep and substance use disorders: an update. Curr Psychiatry Rep. 2014;16:487.

    Article  PubMed  Google Scholar 

  29. Conroy DA, Kurth ME, Strong DR, Brower KJ, Stein MD. Marijuana use patterns and sleep among community-based young adults. J Addict Dis. 2016;35:135–43.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Croche Santander B, Alonso Salas MT, Loscertales Abril M. Accidental cannabis poisoning in children: report of four cases in a tertiary care center from southern Spain. Arch Argent Pediatr. 2011;109:4–7.

    PubMed  Google Scholar 

  31. Daniulaityte R, Nahhas RW, Wijeratne S, Carlson RG, Lamy FR, Martins SS, Boyer EW, Smith GA, Sheth A. “Time for dabs”: analyzing Twitter data on marijuana concentrates across the U.S. Drug Alcohol Depend. 2015;155:307–11.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Dart RC, Bronstein AC, Spyker DA, Cantilena LR, Seifert SA, Heard SE, Krenzelok EP. Poisoning in the United States: 2012 emergency medicine report of the National Poison Data System. Ann Emerg Med. 2015;65:416–22.

    Article  PubMed  Google Scholar 

  33. Davis C, Boddington D. Teenage cardiac arrest following abuse of synthetic cannabis. Heart Lung Circ. 2015;24:e162–3.

    Article  CAS  PubMed  Google Scholar 

  34. De Petrocellis L, Ligresti A, Schiano Moriello A, Iappelli M, Verde R, Stott CG, Cristino L, Orlando P, Di Marzo V. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms. Br J Pharmacol. 2013;168:79–102.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Desai R, Patel U, Deshmukh A, Sachdeva R, Kumar G. Burden of arrhythmia in recreational marijuana users. Int J Cardiol. 2018;

    Google Scholar 

  36. Dines AM, Wood DM, Galicia M, Yates CM, Heyerdahl F, Hovda KE, Giraudon I, Sedefov R, Euro DENRG, PI D. Presentations to the emergency department following Cannabis use: a Multi-Centre Case Series from Ten European Countries. J Med Toxicol. 2015;11:415–21.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Draz EI, Oreby MM, Elsheikh EA, Khedr LA, Atlam SA. Marijuana use in acute coronary syndromes. Am J Drug Alcohol Abuse. 2017;43:576–82.

    Article  PubMed  Google Scholar 

  38. du Plessis SS, Agarwal A, Syriac A. Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility. J Assist Reprod Genet. 2015;32:1575–88.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Duchene C, Olindo S, Chausson N, Jeannin S, Cohen-Tenoudji P, Smadja D. Cannabis-induced cerebral and myocardial infarction in a young woman. Rev Neurol. 2010;166:438–42.

    Article  CAS  PubMed  Google Scholar 

  40. ElSohly M, Gul W. Constituents of cannabis sativa. In: Pertwee RG, editor. Handbook of Cannabis. Oxford: Oxford University Press; 2014. p. 22.

    Google Scholar 

  41. ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in Cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States. Biol Psychiatry. 2016;79:613–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. FDA. MARINOL (dronabinol) capsules, for oral use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018651s029lbl.pdf. Accessed 27 Apr 2018.

  43. Fischer B, Russell C, Sabioni P, van den Brink W, Le Foll B, Hall W, Rehm J, and Room R. Lower-Risk Cannabis use guidelines: a comprehensive update of evidence and recommendations. Am J Public Health 107: 1277, 2017.

    Article  Google Scholar 

  44. Fligiel SE, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest. 1997;112:319–26.

    Article  CAS  PubMed  Google Scholar 

  45. Fonseca BM, Correia-da-Silva G, Teixeira NA. Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis. J Physiol Biochem. 2018;74(2):261–72.

    Article  CAS  PubMed  Google Scholar 

  46. Franz CA, Frishman WH. Marijuana use and cardiovascular disease. Cardiol Rev. 2016;24:158–62.

    Article  PubMed  Google Scholar 

  47. Gates P, Albertella L, Copeland J. Cannabis withdrawal and sleep: A systematic review of human studies. Subst Abus. 2016;37:255–69.

    Article  PubMed  Google Scholar 

  48. Gates PJ, Albertella L, Copeland J. The effects of cannabinoid administration on sleep: a systematic review of human studies. Sleep Med Rev. 2014;18:477–87.

    Article  PubMed  Google Scholar 

  49. Ghannem M, Belhadj I, Tritar A, Moukala T, Amri N, Noury A, Zaghdoudi M. Cannabis and acute coronary syndrome with ST segment elevation. Ann Cardiol Angeiol (Paris). 2013;62:424–8.

    Article  CAS  Google Scholar 

  50. Gorelick DA, Goodwin RS, Schwilke E, Schroeder JR, Schwope DM, Kelly DL, Ortemann-Renon C, Bonnet D, Huestis MA. Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers. Am J Addict. 2013;22:510–4.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Gorzalka BB, Dang SS. Minireview: endocannabinoids and gonadal hormones: bidirectional interactions in physiology and behavior. Endocrinology. 2012;153:1016–24.

    Article  CAS  PubMed  Google Scholar 

  52. Goyal H, Awad HH, Ghali JK. Role of cannabis in cardiovascular disorders. J Thorac Dis. 2017;9:2079–92.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Grotenhermen F. Cannabis-associated arteritis. VASA Zeitschrift fur Gefasskrankheiten. 2010;39:43–53.

    Article  CAS  PubMed  Google Scholar 

  54. Gunawardena MD, Rajapakse S, Herath J, and Amarasena N. Myocardial infarction following cannabis induced coronary vasospasm. BMJ Case Rep 2014: 2014.

    Google Scholar 

  55. Gunn JK, Rosales CB, Center KE, Nunez A, Gibson SJ, Christ C, Ehiri JE. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open. 2016;6:e009986.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Gurney J, Shaw C, Stanley J, Signal V, Sarfati D. Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis. BMC Cancer. 2015;15:897.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009;374:1383–91.

    Article  CAS  PubMed  Google Scholar 

  58. Hall W, Pacula R. Cannabis use and dependence: public health and public policy. Cambridge: Cambridge University Press; 2003.

    Book  Google Scholar 

  59. Hall W, Swift W. The THC content of cannabis in Australia: evidence and policy implications. Aust N Z J Public Health. 2000;24:503–8.

    Article  CAS  PubMed  Google Scholar 

  60. Hancock-Allen JB, Barker L, VanDyke M, Holmes DB. Notes from the field: death following ingestion of an Edible Marijuana Product--Colorado, March 2014. MMWR Morb Mortal Wkly Rep. 2015;64:771–2.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Hartman RL, Richman JE, Hayes CE, Huestis MA. Drug Recognition Expert (DRE) examination characteristics of cannabis impairment. Accid Anal Prev. 2016;92:219–29.

    Article  PubMed  Google Scholar 

  62. Hasler BP, Kirisci L, Clark DB. Restless Sleep and Variable Sleep Timing During Late Childhood Accelerate the Onset of Alcohol and Other Drug Involvement. J Stud Alcohol Drugs. 2016;77:649–55.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Heard K, Marlin MB, Nappe T, CO H. Common marijuana-related cases encountered in the emergency department. Am J Health Syst Pharm. 1904-1908;74, 2017

    Google Scholar 

  64. Helyes Z, Kemeny A, Cseko K, Szoke E, Elekes K, Mester M, Sandor K, Perkecz A, Kereskai L, Mark L, Bona A, Benko A, Pinter E, Szolcsanyi J, Ledent C, Sperlagh B, Molnar TF. Marijuana smoke induces severe pulmonary hyperresponsiveness, inflammation, and emphysema in a predictive mouse model not via CB1 receptor activation. Am J Physiol Lung Cell Mol Physiol. 2017;313:L267–77.

    Article  CAS  PubMed  Google Scholar 

  65. Hodcroft CJ, Rossiter MC, Buch AN. Cannabis-associated myocardial infarction in a young man with normal coronary arteries. J Emerg Med. 2014;47:277–81.

    Article  PubMed  Google Scholar 

  66. Hoffman DBK, Gori GB, Wynder EL. On the carcinogenicity of marijuana smoke. In: Runeckles VC, editor. Recent advances in phytochemistry. Boston: Springer; 1975. p. 63–81.

    Chapter  Google Scholar 

  67. Hoffmann D, Gori G, Wynder E. On the carcinogenicity of marijuana smoke. In: Runeckles VC, editor. Recent advances in phytochemistry. New York: Plenum Press; 1975. p. 63–81.

    Chapter  Google Scholar 

  68. Huang YH, Zhang ZF, Tashkin DP, Feng B, Straif K, Hashibe M. An epidemiologic review of marijuana and cancer: an update. Cancer Epidemiol Biomark Prev. 2015;24:15–31.

    Article  CAS  Google Scholar 

  69. Huber GL, First MW, Grubner O. Marijuana and tobacco smoke gas-phase cytotoxins. Pharmacol Biochem Behav. 1991;40:629–36.

    Article  CAS  PubMed  Google Scholar 

  70. Jamal A, Homa DM, O’Connor E, Babb SD, Caraballo RS, Singh T, Hu SS, King BA. Current cigarette smoking among adults—United States, 2005–2014. Morb Mortal Wkly Rep. 2015;64:1233–40.

    Article  Google Scholar 

  71. Jett J, Stone E, Warren G, Cummings KM. Cannabis use, lung cancer, and related issues. J Thorac Oncol. 2018;13:480–7.

    Article  PubMed  Google Scholar 

  72. Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol. 2002;42:58S–63S.

    Article  CAS  PubMed  Google Scholar 

  73. Joseph P, Leong D, McKee M, Anand SS, Schwalm JD, Teo K, Mente A, Yusuf S. Reducing the global burden of cardiovascular disease, Part 1: the epidemiology and risk factors. Circ Res. 2017;121:677–94.

    Article  CAS  PubMed  Google Scholar 

  74. Jouanjus E, Lapeyre-Mestre M, Micallef J. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart Assoc. 2014;3:e000638.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Kaneko S. Motor vehicle collisions caused by the ‘super-strength’ synthetic cannabinoids, MAM-2201, 5F-PB-22, 5F-AB-PINACA, 5F-AMB and 5F-ADB in Japan experienced from 2012 to 2014. Forensic toxicology. 2017;35:244–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Karila L, Benyamina A, Blecha L, Cottencin O, Billieux J. The Synthetic Cannabinoids Phenomenon. Curr Pharm Des. 2016;22:6420–5.

    Article  CAS  PubMed  Google Scholar 

  77. Kast KA, Gershengoren L. Cannabinoid hyperemesis syndrome and the consulting psychiatrist: a case study of diagnosis and treatment for an emerging disorder in psychiatric practice. J Psychiatr Pract. 2018;24:51–5.

    PubMed  Google Scholar 

  78. Kelly B, Baur LA, Bauman AE, King L. Tobacco and alcohol sponsorship of sporting events provide insights about how food and beverage sponsorship may affect children’s health. Health Promot Pract. 2011;22:91–6.

    Google Scholar 

  79. Kempker JA, Honig EG, Martin GS. The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study. Ann Am Thorac Soc. 2015;12:135–41.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Kim W, Lao Q, Shin YK, Carlson OD, Lee EK, Gorospe M, Kulkarni RN, Egan JM. Cannabinoids induce pancreatic beta-cell death by directly inhibiting insulin receptor activation. Sci Signal. 2012;5:ra23.

    PubMed  PubMed Central  Google Scholar 

  81. King LA, Carpentier C, Griffiths P. Cannabis potency in Europe. Addiction. 2005;100:884–6.

    Article  PubMed  Google Scholar 

  82. Kocabay G, Yildiz M, Duran NE, Ozkan M. Acute inferior myocardial infarction due to cannabis smoking in a young man. J Cardiovasc Med. 2009;10:669–70.

    Article  Google Scholar 

  83. Kochanek KD, Murphy SL, Xu JQ, Tejada-Vera B. Deaths: final data for 2014. National Vital Stat Rep 65(4):1–121. edited by HHS. Hyattsville: National Center for Health Statistics, 2016.

    Google Scholar 

  84. Kong G, Krishnan-Sarin S. A call to end the epidemic of adolescent E-cigarette use. Drug Alcohol Depend. 2017;174:215–21.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Krauss MJ, Sowles SJ, Sehi A, Spitznagel EL, Berg CJ, Bierut LJ, Cavazos-Rehg PA. Marijuana advertising exposure among current marijuana users in the U.S. Drug Alcohol Depend. 2017;174:192–200.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Le Garrec S, Dauger S, Sachs P. Cannabis poisoning in children. Intensive Care Med. 2014;40:1394–5.

    Article  PubMed  Google Scholar 

  87. Lee MH, Hancox RJ. Effects of smoking cannabis on lung function. Expert Rev Respir Med. 2011;5:537–46.

    Article  CAS  PubMed  Google Scholar 

  88. Lee SY, Oh SM, Chung KH. Estrogenic effects of marijuana smoke condensate and cannabinoid compounds. Toxicol Appl Pharmacol. 2006;214:270–8.

    Article  CAS  PubMed  Google Scholar 

  89. Leemaqz SY, Dekker GA, McCowan LM, Kenny LC, Myers JE, Simpson NA, Poston L, Roberts CT, Consortium S. Maternal marijuana use has independent effects on risk for spontaneous preterm birth but not other common late pregnancy complications. Reprod Toxicol. 2016;62:77–86.

    Article  CAS  PubMed  Google Scholar 

  90. Liu J, Zhou L, Xiong K, Godlewski G, Mukhopadhyay B, Tam J, Yin S, Gao P, Shan X, Pickel J, Bataller R, O’Hare J, Scherer T, Buettner C, Kunos G. Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. Gastroenterology. 2012;142:1218–1228-e1211.

    Article  CAS  PubMed  Google Scholar 

  91. Ly C, Gehricke JG. Marijuana use is associated with inattention in men and sleep quality in women with Attention-Deficit/Hyperactivity Disorder: a preliminary study. Psychiatry Res. 2013;210:1310–2.

    Article  PubMed  Google Scholar 

  92. Maccarrone M, Bab I, Biro T, Cabral GA, Dey SK, Di Marzo V, Konje JC, Kunos G, Mechoulam R, Pacher P, Sharkey KA, Zimmer A. Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol Sci. 2015;36:277–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Macleod J, Robertson R, Copeland L, McKenzie J, Elton R, Reid P. Cannabis, tobacco smoking, and lung function: a cross-sectional observational study in a general practice population. Br J Gen Pract. 2015;65:e89–95.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Marchetti D, Spagnolo A, De Matteis V, Filograna L, De Giovanni N. Coronary thrombosis and marijuana smoking: a case report and narrative review of the literature. Drug Test Anal. 2016;8:56–62.

    Article  PubMed  CAS  Google Scholar 

  95. Martinasek MP, McGrogan JB, Maysonet A. A systematic review of the respiratory effects of inhalational marijuana. Respir Care. 2016;61:1543–51.

    Article  PubMed  Google Scholar 

  96. Meier MH, Caspi A, Cerda M, Hancox RJ, Harrington H, Houts R, Poulton R, Ramrakha S, Thomson WM, Moffitt TE. Associations between Cannabis use and physical health problems in early midlife: a longitudinal comparison of persistent Cannabis vs Tobacco users. JAMA Psychiatry. 2016;73:731–40.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  97. Menahem S. Cardiac asystole following cannabis (marijuana) usage--additional mechanism for sudden death? Forensic Sci Int. 2013;233:e3–5.

    Article  CAS  PubMed  Google Scholar 

  98. Mike TB, Shaw DS, Forbes EE, Sitnick SL, Hasler BP. The hazards of bad sleep-Sleep duration and quality as predictors of adolescent alcohol and cannabis use. Drug Alcohol Depend. 2016;168:335–9.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Miller MB, Janssen T, Jackson KM. The prospective association between sleep and initiation of substance use in young adolescents. J Adolesc Health. 2017;60:154–60.

    Article  PubMed  Google Scholar 

  100. Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103:2805–9.

    Article  CAS  PubMed  Google Scholar 

  101. Moir D, Rickert WS, Levasseur G, Larose Y, Maertens R, White P, Desjardins S. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol. 2008;21:494–502.

    Article  CAS  PubMed  Google Scholar 

  102. Moon AM, Buckley SA, NM M. Successful treatment of cannabinoid hyperemesis syndrome with topical capsaicin. ACG Case Rep J. 2018;5:e3.

    PubMed  PubMed Central  Google Scholar 

  103. Morean ME, Kong G, Camenga DR, Cavallo DA, Krishnan-Sarin S. High school students’ use of electronic cigarettes to Vaporize Cannabis. Pediatrics. 2015;136:611–6.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Mukhopadhyay P, Batkai S, Rajesh M, Czifra N, Harvey-White J, Hasko G, Zsengeller Z, Gerard NP, Liaudet L, Kunos G, Pacher P. Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity. J Am Coll Cardiol. 2007;50:528–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Muniyappa R, Sable S, Ouwerkerk R, Mari A, Gharib AM, Walter M, Courville A, Hall G, Chen KY, Volkow ND, Kunos G, Huestis MA, Skarulis MC. Metabolic effects of chronic cannabis smoking. Diabetes Care. 2013;36:2415–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. NASEM. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research Washington, DC: Committee on the Health effects of marijuana: An Evidence Review and Research Agenda, 2017.

    Google Scholar 

  107. Nguyen-Louie TT, Brumback T, Worley MJ, Colrain IM, Matt GE, Squeglia LM, Tapert SF. Effects of sleep on substance use in adolescents: a longitudinal perspective. Addict Biol. 2018;23(2):750–60.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Nicholson AN, Turner C, Stone BM, Robson PJ. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol. 2004;24:305–13.

    Article  CAS  PubMed  Google Scholar 

  109. Novotný M, Merli F, Wiesler D, Fencl M, Saeed T. Fractionation and capillary gas chromatographic—mass spectrometric characterization of the neutral components in marijuana and tobacco smoke condensates. J Chromatogr A. 1982;238:141–50.

    Article  Google Scholar 

  110. Nowlan R, Cohen S. Tolerance to marijuana: heart rate and subjective “high”. Clin Pharmacol Ther. 1977;22:550–6.

    Article  CAS  PubMed  Google Scholar 

  111. Ogeil RP, Phillips JG, Rajaratnam SM, Broadbear JH. Risky drug use and effects on sleep quality and daytime sleepiness. Hum Psychopharmacol. 2015;30:356–63.

    Article  PubMed  Google Scholar 

  112. Okamoto T, Chan PC, BT S. Effect of tobacco, marijuana and benzo(a)pyrene on aryl hydrocarbon hydroxylase in hamster lung. Life Sci Pt 2. 1972;11:733–41.

    Article  CAS  Google Scholar 

  113. Owen KP, Sutter ME, Albertson TE. Marijuana: respiratory tract effects. Clin Rev Allergy Immunol. 2014;46:65–81.

    Article  CAS  PubMed  Google Scholar 

  114. Pacher P, Steffens S, Hasko G, Schindler TH, Kunos G. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Nat Rev Cardiol. 2018;15:151–66.

    Article  CAS  PubMed  Google Scholar 

  115. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev. 2006;27:73–100.

    Article  CAS  PubMed  Google Scholar 

  116. Pasch KE, Latimer LA, Cance JD, Moe SG, Lytle LA. Longitudinal bi-directional relationships between sleep and youth substance use. J Youth Adolesc. 2012;41:1184–96.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Perron RR, Tyson RL, GR S. Delta9 -tetrahydrocannabinol increases brain temperature and inverts circadian rhythms. Neuroreport. 2001;12:3791–4.

    Article  CAS  PubMed  Google Scholar 

  118. Peyrot I, Garsaud AM, Saint-Cyr I, Quitman O, Sanchez B, Quist D. Cannabis arteritis: a new case report and a review of literature. JEADV. 2007;21:388–91.

    CAS  PubMed  Google Scholar 

  119. Phillips HR, 3rd, Smith DA. A patient with a curious case of cyclical vomiting. JAAPA 2017; 30: 1–3.

    Article  PubMed  Google Scholar 

  120. Pivik RT, Zarcone V, Dement WC, Hollister LE. Delta-9-tetrahydrocannabinol and synhexl: effects on human sleep patterns. Clin Pharmacol Ther. 1972;13:426–35.

    Article  CAS  PubMed  Google Scholar 

  121. Pranikoff K, Karacan I, Larson EA, Williams RL, Thornby JI, Hursch CJ. Effects of marijuana smoking on the sleep EEG. Preliminary studies. JFMA. 1973;60:28–31.

    CAS  PubMed  Google Scholar 

  122. Raber JC, Elzinga S, Kaplan C. Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. J Toxicol Sci. 2015;40:797–803.

    Article  PubMed  Google Scholar 

  123. Ribeiro LI, Ind PW. Effect of cannabis smoking on lung function and respiratory symptoms: a structured literature review. NPJ Prim Care Respir Med. 2016;26:16071.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Richards JR. Cannabinoid hyperemesis syndrome: pathophysiology and treatment in the emergency department. J Emerg Med. 2018;54:354–63.

    Article  PubMed  Google Scholar 

  125. Richards JR, Lapoint JM, Burillo-Putze G. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment. Clin Toxicol. 2018;56:15–24.

    Article  CAS  Google Scholar 

  126. Rivera-Chavarria IJ, Brenes-Gutierrez JD. Thromboangiitis obliterans (Buerger’s disease). Ann Med Surg. 2016;7:79–82.

    Article  Google Scholar 

  127. Roberson EK, Patrick WK, Hurwitz EL. Marijuana use and maternal experiences of severe nausea during pregnancy in Hawai’i. Hawaii J Med Public Health. 2014;73:283–7.

    PubMed  PubMed Central  Google Scholar 

  128. Roth MD, Arora A, Barsky SH, Kleerup EC, Simmons M, Tashkin DP. Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med. 1998;157:928–37.

    Article  CAS  PubMed  Google Scholar 

  129. Safaa AM, Markham R, Jayasinghe R. Marijuana-induced recurrent acute coronary syndrome with normal coronary angiograms. Drug Alcohol Rev. 2012;31:91–4.

    Article  PubMed  Google Scholar 

  130. Salani DA, Zdanowicz MM. Synthetic cannabinoids: the dangers of spicing it up. J Psychosoc Nurs Ment Health Serv. 2015;53:36–43.

    Article  PubMed  Google Scholar 

  131. Santos RP, Resende CI, Vieira AP, Brito C. Cannabis arteritis: ever more important to consider. BMJ Case Rep. 2017;2017

    Google Scholar 

  132. Schaich CL, Shaltout HA, Brosnihan KB, Howlett AC, Diz DI. Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats. Phys Rep. 2014;2

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  133. Sidney S. Cardiovascular consequences of marijuana use. J Clin Pharmacol. 2002;42:64S–70S.

    Article  CAS  PubMed  Google Scholar 

  134. Sidney S. Marijuana use and type 2 diabetes mellitus: a review. Curr Diab Rep. 2016;16:117.

    Article  PubMed  Google Scholar 

  135. Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, AA M. Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment-a systematic review. J Med Toxicol. 2017;13:71–87.

    Article  CAS  PubMed  Google Scholar 

  136. Tashkin DP. Does cannabis use predispose to chronic airflow obstruction? Eur Respir J. 2010;35:3–5.

    Article  CAS  PubMed  Google Scholar 

  137. Tashkin DP. Effects of marijuana smoking on the lung. Ann Am Thorac Soc. 2013;10:239–47.

    Article  CAS  PubMed  Google Scholar 

  138. Tashkin DP, Reiss S, Shapiro BJ, Calvarese B, Olsen JL, Lodge JW. Bronchial effects of aerosolized delta 9-tetrahydrocannabinol in healthy and asthmatic subjects. Am Rev Respir Dis. 1977;115:57–65.

    CAS  PubMed  Google Scholar 

  139. Tashkin DP, Shapiro BJ, IM F. Acute pulmonary physiologic effects of smoked marijuana and oral (Delta)9 -tetrahydrocannabinol in healthy young men. N Engl J Med. 1973;289:336–41.

    Article  CAS  PubMed  Google Scholar 

  140. Teixeira D, Pestana D, Faria A, Calhau C, Azevedo I, Monteiro R. Modulation of adipocyte biology by delta(9)-tetrahydrocannabinol. Obesity. 2010;18:2077–85.

    Article  PubMed  Google Scholar 

  141. Thomas G, Kloner RA, Rezkalla S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol. 2014;113:187–90.

    Article  CAS  PubMed  Google Scholar 

  142. Tormey WP. Cannabis, possible cardiac deaths and the coroner in Ireland. Ir J Med Sci. 2012;181:479–82.

    Article  CAS  PubMed  Google Scholar 

  143. Troutt WD, DiDonato MD. Carbonyl compounds produced by vaporizing Cannabis oil thinning agents. J Altern Complement Med. 2017;23:879–84.

    Article  PubMed  Google Scholar 

  144. Uban KA, Horton MK, Jacobus J, Heyser C, Thompson WK, Tapert SF, Madden PAF, Sowell ER, and Adolescent Brain Cognitive Development S. Biospecimens and the ABCD study: Rationale, methods of collection, measurement and early data. Dev Cogn Neurosci. 2018;32:97–106.

    Article  PubMed  PubMed Central  Google Scholar 

  145. Vandrey RG, Budney AJ, Hughes JR, Liguori A. A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances. Drug Alcohol Depend. 2008;92:48–54.

    Article  CAS  PubMed  Google Scholar 

  146. Velibey Y, Sahin S, Tanik O, Keskin M, Bolca O, Eren M. Acute myocardial infarction due to marijuana smoking in a young man: guilty should not be underestimated. Am J Emerg Med. 2015;33:1114–3.

    Article  PubMed  Google Scholar 

  147. Whitehurst LN, Fogler K, Hall K, Hartmann M, Dyche J. The effects of chronic marijuana use on circadian entrainment. Chronobiol Int. 2015;32:561–7.

    Article  PubMed  Google Scholar 

  148. WHO. Management of Substance Abuse: Cannabis http://www.who.int/substance_abuse/facts/cannabis/en/.

  149. Witkamp RF. The role of fatty acids and their endocannabinoid-like derivatives in the molecular regulation of appetite. Mol Aspects Med. 2018;S0098–2997(17):30142–5. https://doi.org/10.1016/j.mam.2018.01.002. [Epub ahead of print] Review.

    Article  CAS  PubMed  Google Scholar 

  150. Wolff V, Jouanjus E. Strokes are possible complications of cannabinoids use. E&B. 2017;70:355–63.

    Google Scholar 

  151. Writing Group M, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, American Heart Association Statistics C, and Stroke Statistics S. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 2016; 133: e38–360.

    Google Scholar 

  152. Wu TC, Tashkin DP, Djahed B, JE R. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med. 1988;318:347–51.

    Article  CAS  PubMed  Google Scholar 

  153. Zhang LR, Morgenstern H, Greenland S, Chang SC, Lazarus P, Teare MD, Woll PJ, Orlow I, Cox B, Brhane Y, Liu G, RJ H. Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium. Int J Cancer. 2015;136:894–903.

    Article  CAS  PubMed  Google Scholar 

  154. Zhu H, Wu LT. Trends and correlates of Cannabis-involved emergency department visits: 2004 to 2011. J Addict Med. 2016;10:429–36.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Disclaimer

The opinions in this paper are of authors and do not reflect the position of the National Institute on Drug Abuse, National Institutes of Health.

Author information

Authors and Affiliations

  1. Division of Therapeutics and Medical Consequences, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA

    Jag H. Khalsa

  2. Office of Science Policy and Communications, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA

    Ruben Baler

Authors
  1. Jag H. Khalsa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ruben Baler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jag H. Khalsa .

Editor information

Editors and Affiliations

  1. Division of Pharma & Med Cons Drug Abuse, NIDA, NIH, Department of Health & Human Services, Bethesda, MD, USA

    Ivan D. Montoya

  2. Division of Extramural Research, National Institute on Drug Abuse Division of Extramural Research, Bethesda, MD, USA

    Susan R. B. Weiss

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Khalsa, J.H., Baler, R. (2019). Medical Consequences of Cannabis Use. In: Montoya, I., Weiss, S. (eds) Cannabis Use Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-90365-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90365-1_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90364-4

  • Online ISBN: 978-3-319-90365-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation